25
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID‐19

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Despite the urgent need for remote neurobehavioral assessment of individuals with cognitive impairment, guidance is lacking. Our goal is to provide a multi‐dimensional framework for remotely assessing cognitive, functional, behavioral, and physical aspects of people with cognitive impairment, along with ethical and technical considerations.

          Methods

          Literature review on remote cognitive assessment and multidisciplinary expert opinion from behavioral neurologists, neuropsychiatrists, neuropsychologists, and geriatricians was integrated under the auspices of the Alzheimer Society of Canada Task Force on Dementia Care Best Practices for COVID‐19. Telephone and video approaches to assessments were considered.

          Results

          Remote assessment is shown to be acceptable to patients and caregivers. Informed consent, informant history, and attention to privacy and autonomy are paramount. A range of screening and domain‐specific instruments are available for telephone or video assessment of cognition, function, and behavior. Some neuropsychological tests administered by videoconferencing show good agreement with in‐person assessment but still lack validation and norms. Aspects of the remote dementia‐focused neurological examination can be performed reliably.

          Discussion

          Despite challenges, current literature and practice support implementation of telemedicine assessments for patients with cognitive impairment. Convergence of data across the clinical interview, reliable and brief remote cognitive tests, and remote neurological exam increase confidence in clinical interpretation and diagnosis.

          Related collections

          Most cited references57

          • Record: found
          • Abstract: found
          • Article: not found

          Development and validation of the Penn State Worry Questionnaire.

          The present report describes the development of the Penn State Worry Questionnaire to measure the trait of worry. The 16-item instrument emerged from factor analysis of a large number of items and was found to possess high internal consistency and good test-retest reliability. The questionnaire correlates predictably with several psychological measures reasonably related to worry, and does not correlate with other measures more remote to the construct. Responses to the questionnaire are not influenced by social desirability. The measure was found to significantly discriminate college samples (a) who met all, some, or none of the DSM-III-R diagnostic criteria for generalized anxiety disorder and (b) who met criteria for GAD vs posttraumatic stress disorder. Among 34 GAD-diagnosed clinical subjects, the worry questionnaire was found not to correlate with other measures of anxiety or depression, indicating that it is tapping an independent construct with severely anxious individuals, and coping desensitization plus cognitive therapy was found to produce significantly greater reductions in the measure than did a nondirective therapy condition.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Dementia care during COVID-19

            Older adults are vulnerable at the onset of natural disasters and crisis, and this has been especially true during the coronavirus disease 2019 (COVID-19) pandemic. 1 With the aggressive spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the death toll has risen worldwide. According to an interactive online tool that estimates the potential number of deaths from COVID-19 in a population, by age group, in individual countries and regional groupings worldwide under a range of scenarios, most of those who have died were older adults, most of whom had underlying health problems. 2 Globally, more than 50 million people have dementia, and one new case occurs every 3 s. 3 Dementia has emerged as a pandemic in an ageing society. 4 The double hit of dementia and COVID-19 pandemics has raised great concerns for people living with dementia. People living with dementia have limited access to accurate information and facts about the COVID-19 pandemic. They might have difficulties in remembering safeguard procedures, such as wearing masks, or in understanding the public health information issued to them. Ignoring the warnings and lacking sufficient self-quarantine measures could expose them to higher chance of infection. Older people in many countries, unlike in China, tend to live alone or with their spouse, either at home or in nursing homes. As more and more businesses stop non-essential services or initiate telecommuting work in an attempt to maintain social distancing limit the further spread of SARS-CoV-2, people living with dementia, who have little knowledge of telecommunication and depend primarily on in-person support might feel lonely and abandoned, and become withdrawn. To lessen the chance of infection among older people in nursing homes, more local authorities are banning visitors to nursing homes and long-term care facilities. 5 In January, 2020, the Chinese Ministry of Civil Affairs implemented similar social-distancing measures. 6 As a result, older residents lost face-to-face contact with their family members. Group activities in nursing homes were also prohibited. As a consequence, the residents of nursing homes became more socially isolated. We have observed that under the dual stress of fear of infection and worries about the residents' condition, the level of anxiety among staff in nursing homes increased and they developed signs of exhaustion and burnout after a month-long full lockdown of the facilities. Some people infected with COVID-19 have had to receive intensive care in hospital. A new environment can lead to increased stress and behavioural problems. 7 Delirium caused by hypoxia, a prominent clinical feature of COVID-19, could complicate the presentation of dementia 8 , increasing the suffering of the people living with dementia, the cost of medical care, and the need for dementia support. During the COVID-19 outbreak in China, five organisations, including the Chinese Society of Geriatric Psychiatry and Alzheimer's Disease Chinese, promptly released expert recommendations and disseminated key messages on how to provide mental health and psychosocial support. 9 Multidisciplinary teams started counselling services free of charge for people living with dementia and their carers. These approaches minimised the complex impact of both COVID-19 outbreak and dementia. As recommended by international dementia experts and Alzheimer's Disease International, 10 support for people living with dementia and their carers is needed urgently worldwide. In addition to physical protection from virus infection, mental health and psychosocial support should be delivered. For example, mental health professionals, social workers, nursing home administrators, and volunteers should deliver mental health care for people living with dementia collaboratively. Within such a team, dementia experts could take the lead and support team members from other disciplines. Self-help guidance for reducing stress, such as relaxation or meditation exercise, could be delivered through electronic media. Service teams could support behavioural management through telephone hotlines. Psychological counsellors could provide online consultation for carers at home and in nursing homes. 11 In addition, we encourage people who have a parent with dementia to have more frequent contact or spend more time with their parent, or to take on some of the caregiving duties so as to give the carer some respite time. China has contained the epidemic, and business is starting to return to normal. We believe that learning lessons from China would empower the world to tackle the COVID-19 pandemic, with little risk of compromising the quality of life of people living with dementia and their carers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence of Depression in Patients With Mild Cognitive Impairment: A Systematic Review and Meta-analysis.

              Depression is common in individuals with mild cognitive impairment (MCI) and may confer a higher likelihood of progression to dementia. Prevalence estimates of depression in those with MCI are required to guide both clinical decisions and public health policy, but published results are variable and lack precision.
                Bookmark

                Author and article information

                Contributors
                maiya.geddes@mcgill.ca
                Journal
                Alzheimers Dement (Amst)
                Alzheimers Dement (Amst)
                10.1002/(ISSN)2352-8729
                DAD2
                Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
                John Wiley and Sons Inc. (Hoboken )
                2352-8729
                22 September 2020
                2020
                : 12
                : 1 ( doiID: 10.1002/dad2.v12.1 )
                : e12111
                Affiliations
                [ 1 ] Department of Neurology and Neurosurgery Montreal Neurological Institute McGill University Montreal Canada
                [ 2 ] McGill Center for Studies in Aging McGill University Verdun Canada
                [ 3 ] Departments of Psychiatry and Neurology Brigham and Women's Hospital Harvard Medical School Boston USA
                [ 4 ] Department of Psychology University of Saskatchewan Saskatoon Canada
                [ 5 ] Canadian Center for Health & Safety in Agriculture Medicine University of Saskatchewan Saskatoon Canada
                [ 6 ] Department of Psychiatry Dalhousie University Halifax Canada
                [ 7 ] Department of Psychology and Neuroscience Dalhousie University Halifax Canada
                [ 8 ] Department of Medicine Dalhousie University Halifax Canada
                [ 9 ] Neuroscience and Mental Health Institute and Department of Medicine Division of Neurology University of Alberta Edmonton Canada
                [ 10 ] Departments of Psychiatry, Clinical Neurosciences, and Community Health Sciences Cumming School of Medicine University of Calgary Calgary Alberta Canada
                [ 11 ] Hotchkiss Brain Institute O'Brien Institute for Public Health University of Calgary Calgary Alberta Canada
                Author notes
                [*] [* ] Correspondence

                Dr. Maiya Geddes, 3801 Rue University, Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada.

                Email: maiya.geddes@ 123456mcgill.ca

                Article
                DAD212111
                10.1002/dad2.12111
                7507991
                32999916
                432b758a-855e-449d-8c99-e5e0e0af43dc
                © 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 21 August 2020
                : 26 August 2020
                Page count
                Figures: 0, Tables: 1, Pages: 11, Words: 8633
                Funding
                Funded by: Canadian Institutes of Health Research , open-funder-registry 10.13039/501100000024;
                Funded by: National Institutes of Health , open-funder-registry 10.13039/100000002;
                Funded by: Sidney Baer Foundation
                Funded by: Fonds de Recherche en Santé du Québec
                Categories
                Review Article
                Cognitive & Behavioral Assessment
                Custom metadata
                2.0
                2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.1 mode:remove_FC converted:22.09.2020

                alzheimer's disease,assessment,cognitive impairment,dementia,telehealth,telemedicine

                Comments

                Comment on this article